XIRP2 and hepatocellular carcinoma: We also found that APOB mutations were primarily distributed in HCC patients with tumors larger than 5 cm (p = 0.037) and XIRP2 mutations were primarily distributed in non-smoking patients (p = 0.002) (Figures 2A, C).